G2B Pharma Inc. logo
G2B Pharma Receives Project Financing From Sosei and Right to In-license Nasal Delivery Technologies From SNBL
August 13, 2014 03:01 ET | G2B Pharma Inc.
SAN FRANCISCO, Aug. 13, 2014 (GLOBE NEWSWIRE) -- G2B Pharma Inc. ('G2B' Chairman and CEO, Nigel Ten Fleming PhD, San Francisco, USA) announces the signing of an agreement with Sosei Group...
G2B Pharma Inc. logo
Novel Nasal Epinephrine Shows Comparable Absorption to EpiPen(R) in a Feasibility Study
September 10, 2013 09:30 ET | G2B Pharma Inc.
SAN FRANCISCO, Sept. 10, 2013 (GLOBE NEWSWIRE) -- Shin Nippon Biomedical Laboratories, Ltd. ('SNBL' Chairman and CEO, Ryoichi Nagata MD PhD FFPM, Tokyo, Japan) and G2B Pharma Inc. ('G2B' Chairman and...